99 related articles for article (PubMed ID: 12954155)
1. Plasmatic nitric oxide, but not von Willebrand Factor, is an early marker of endothelial damage, in type 1 diabetes mellitus patients without microvascular complications.
Correa RC; Alfieri AB
J Diabetes Complications; 2003; 17(5):264-8. PubMed ID: 12954155
[TBL] [Abstract][Full Text] [Related]
2. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study.
Greaves M; Malia RG; Goodfellow K; Mattock M; Stevens LK; Stephenson JM; Fuller JH
Diabetologia; 1997 Jun; 40(6):698-705. PubMed ID: 9222650
[TBL] [Abstract][Full Text] [Related]
3. Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy.
Zimmermann J; Schramm L; Wanner C; Mulzer E; Henrich HA; Langer R; Heidbreder E
Clin Nephrol; 1996 Oct; 46(4):230-6. PubMed ID: 8905207
[TBL] [Abstract][Full Text] [Related]
4. Von Willebrand factor in type 1 diabetes: its production and coronary artery calcification.
Chan NN; Fuller JH; Rubens M; Colhoun HM
Med Sci Monit; 2003 Jul; 9(7):CR297-303. PubMed ID: 12883448
[TBL] [Abstract][Full Text] [Related]
5. Von Willebrand factor in diabetic angiopathy.
Kessler L; Wiesel ML; Attali P; Mossard JM; Cazenave JP; Pinget M
Diabetes Metab; 1998 Sep; 24(4):327-36. PubMed ID: 9805643
[TBL] [Abstract][Full Text] [Related]
6. von Willebrand factor and development of diabetic nephropathy in IDDM.
Stehouwer CD; Stroes ES; Hackeng WH; Mulder PG; Den Ottolander GJ
Diabetes; 1991 Aug; 40(8):971-6. PubMed ID: 1907250
[TBL] [Abstract][Full Text] [Related]
7. Von Willebrand factor could be an index of endothelial dysfunction in patients with cirrhosis: relationship to degree of liver failure and nitric oxide levels.
Albornoz L; Alvarez D; Otaso JC; Gadano A; Salviú J; Gerona S; Sorroche P; Villamil A; Mastai R
J Hepatol; 1999 Mar; 30(3):451-5. PubMed ID: 10190728
[TBL] [Abstract][Full Text] [Related]
8. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.
Targher G; Bertolini L; Zoppini G; Zenari L; Falezza G
Diabet Med; 2005 Aug; 22(8):999-1004. PubMed ID: 16026364
[TBL] [Abstract][Full Text] [Related]
9. von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII).
Vischer UM; Emeis JJ; Bilo HJ; Stehouwer CD; Thomsen C; Rasmussen O; Hermansen K; Wollheim CB; Ingerslev J
Thromb Haemost; 1998 Dec; 80(6):1002-7. PubMed ID: 9869174
[TBL] [Abstract][Full Text] [Related]
10. Association between high von willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes. The GENEDIAB Study Group and the DESIR Study Group.
Lacquemant C; Gaucher C; Delorme C; Chatellier G; Gallois Y; Rodier M; Passa P; Balkau B; Mazurier C; Marre M; Froguel P
Kidney Int; 2000 Apr; 57(4):1437-43. PubMed ID: 10760079
[TBL] [Abstract][Full Text] [Related]
11. Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type II patients.
Ouviña SM; La Greca RD; Zanaro NL; Palmer L; Sassetti B
Thromb Res; 2001 Apr; 102(2):107-14. PubMed ID: 11323020
[TBL] [Abstract][Full Text] [Related]
12. The association of reduced endothelium derived relaxing factor-NO production with endothelial damage and increased in vivo platelet activation in patients with diabetes mellitus.
Huszka M; Kaplar M; Rejto L; Tornai I; Palatka K; Laszlo P; Udvardy M
Thromb Res; 1997 Apr; 86(2):173-80. PubMed ID: 9175238
[TBL] [Abstract][Full Text] [Related]
13. Elevated plasma vascular endothelial cell growth factor and thrombomodulin in juvenile diabetic patients.
McLaren M; Elhadd TA; Greene SA; Belch JJ
Clin Appl Thromb Hemost; 1999 Jan; 5(1):21-4. PubMed ID: 10725978
[TBL] [Abstract][Full Text] [Related]
14. von Willebrand factor, C-reactive protein, nitric oxide, and vascular endothelial growth factor in a dietary reversal model of hypercholesterolemia in rabbit.
Haghjooyjavanmard S; Nematbakhsh M; Monajemi A; Soleimani M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):91-5. PubMed ID: 18795081
[TBL] [Abstract][Full Text] [Related]
15. Changes in the aortic endothelium and plasma von Willebrand factor levels during the onset and progression of insulin-dependent diabetes in BB rats.
Ribau JC; Hatton MW; Richardson M
Atherosclerosis; 1998 Aug; 139(2):291-9. PubMed ID: 9712335
[TBL] [Abstract][Full Text] [Related]
16. Endothelial dysfunction precedes development of microalbuminuria in IDDM.
Stehouwer CD; Fischer HR; van Kuijk AW; Polak BC; Donker AJ
Diabetes; 1995 May; 44(5):561-4. PubMed ID: 7729616
[TBL] [Abstract][Full Text] [Related]
17. Abnormal markers of endothelial cell activation and oxidative stress in children, adolescents and young adults with type 1 diabetes with no clinical vascular disease.
Elhadd TA; Kennedy G; Hill A; McLaren M; Newton RW; Greene SA; Belch JJ
Diabetes Metab Res Rev; 1999; 15(6):405-11. PubMed ID: 10634966
[TBL] [Abstract][Full Text] [Related]
18. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
Hofmann MA; Kohl B; Zumbach MS; Borcea V; Bierhaus A; Henkels M; Amiral J; Schmidt AM; Fiehn W; Ziegler R; Wahl P; Nawroth PP
Diabetes Care; 1998 May; 21(5):841-8. PubMed ID: 9589252
[TBL] [Abstract][Full Text] [Related]
19. Retinopathy in type 2 diabetes mellitus is associated with increased intima-media thickness and endothelial dysfunction.
Malecki MT; Osmenda G; Walus-Miarka M; Skupien J; Cyganek K; Mirkiewicz-Sieradzka B; damek-Guzik TA; Guzik TJ; Sieradzki J
Eur J Clin Invest; 2008 Dec; 38(12):925-30. PubMed ID: 19021717
[TBL] [Abstract][Full Text] [Related]
20. Aortic endothelial cell von Willebrand factor content, and circulating plasminogen activator inhibitor-1 are increased, but expression of endothelial leukocyte adhesion molecules is unchanged in insulin-dependent diabetic BB rats.
Ribau JC; Samis JA; Senis YA; Maurice DH; Giles AR; DeReske M; Absher PM; Hatton MW; Richardson M
Atherosclerosis; 2000 Apr; 149(2):331-42. PubMed ID: 10729383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
